Gilead Sciences Inc. (GILD)

NASDAQ

$165.44

$+6.38

(+4.01%)

Previous Close: ⁦$159.20⁩

Market Closed

Gilead Sciences Inc. (GILD) Live Price Chart

Last updated: ⁦2026-10-30 05:39:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Gilead Sciences Inc. (GILD) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $165.44, with a market capitalization of $197.25B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $114.02 to $165.51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$197.25B
Open	$162.89
Day's High	$165.51
Day's Low	$6.28
Previous Close	$159.20
Volume	6.10M
Average Volume	6.00M
P/E Ratio	--
52-Week High	$165.51
52-Week Low	$114.02
Dividend Yield	2.06%
Earnings Date	2001-12-30

Gilead Sciences Inc. (GILD) Latest Closing Stock Price

Gilead Sciences Inc. (GILD) last closed at $159.20 as of 2026-10-30 00:00:00, unchanged from the previous close of $159.20.

During the latest regular trading session, GILD traded between $6.28 and $165.51, with a volume of 6.10M shares. The closing price was near the upper end and near the upper end of its 52-week range.

Gilead Sciences Inc. (GILD) 7-Day Stock Price Change

Over the past seven days, Gilead Sciences Inc. (GILD) moved from $156.51 to $165.44, representing a gain of 5.70% ($8.93).

The stock traded between $151.71 and $165.51 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 5.75 million shares, down versus the previous seven-day period, indicating lower trading activity.

GILD 52-Week Price Position

Position in Range: 99.9%

52W Low$114.02

52W High$165.51

GILD is currently trading at $165.44, placing it 99.9% of the way from its 52-week low of $114.02 to its 52-week high of $165.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Gilead Sciences Inc. (GILD)?

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Gilead Sciences Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	17000
CEO	Daniel Patrick O'Day
Founded	1987
Exchange	NASDAQ
Company Website	https://www.gilead.com

How to Buy Gilead Sciences Inc. (GILD) Stock on MEXC

Eligible investors can buy real shares of Gilead Sciences Inc. (GILD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GILD and Place Your Order

Open the RealStocks trading page and search for GILD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Gilead Sciences Inc. (GILD) stock price today?

Gilead Sciences Inc. (GILD) is currently trading at $ 165.44, up 3.92% ($6.24) from the previous close of $ 159.20. Intraday prices update in real time during regular trading hours.

2.Is GILD stock going up or down today?

As of 2026-10-30 00:00:00, GILD is trading at $ 165.44, up 3.92% ($6.24) from its previous close of $ 159.20. The stock has traded between $ 6.28 and $ 165.51 during today’s regular session. Past price movements do not guarantee future results.

3.What is GILD pre-market price?

As of 2026-10-30 00:00:00, GILD is trading at $ 163.58 in pre-market trading, up 2.75% ($4.38) from the previous close of $ 159.20. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GILD after-hours price?

As of 2026-10-30 00:00:00, GILD is trading at $ 169.35 in after-hours trading, up 6.38% ($10.15) from the regular-session close of $ 159.20. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GILD stock trading now?

GILD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GILD sit relative to its 52-week high and low?

Over the past 52 weeks, GILD has traded between a low of $ 114.02 and a high of $ 165.51. At $ 165.44, the stock is positioned 99.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Gilead Sciences Inc. in?

Gilead Sciences Inc. (GILD) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Gilead Sciences Inc.'s market capitalization and where is it listed?

Gilead Sciences Inc. is listed on the NASDAQ exchange with a market capitalization of $ 197.25B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GILD valued in terms of P/E ratio and EPS?

GILD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.61. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Gilead Sciences Inc. pay a dividend?

Gilead Sciences Inc. pays an indicated annual cash dividend of $ 3.41 per share, with a current dividend yield of 2.06% based on the latest share price. Dividend policies are subject to change at the board's discretion.